1. Home
  2. GANX vs CFSB Comparison

GANX vs CFSB Comparison

Compare GANX & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • CFSB
  • Stock Information
  • Founded
  • GANX 2017
  • CFSB 1889
  • Country
  • GANX United States
  • CFSB United States
  • Employees
  • GANX N/A
  • CFSB N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • CFSB Major Banks
  • Sector
  • GANX Health Care
  • CFSB Finance
  • Exchange
  • GANX Nasdaq
  • CFSB Nasdaq
  • Market Cap
  • GANX 53.4M
  • CFSB 51.6M
  • IPO Year
  • GANX 2021
  • CFSB N/A
  • Fundamental
  • Price
  • GANX $1.92
  • CFSB $13.95
  • Analyst Decision
  • GANX Strong Buy
  • CFSB
  • Analyst Count
  • GANX 5
  • CFSB 0
  • Target Price
  • GANX $8.00
  • CFSB N/A
  • AVG Volume (30 Days)
  • GANX 378.4K
  • CFSB 1.1K
  • Earning Date
  • GANX 08-12-2025
  • CFSB 09-09-2025
  • Dividend Yield
  • GANX N/A
  • CFSB N/A
  • EPS Growth
  • GANX N/A
  • CFSB N/A
  • EPS
  • GANX N/A
  • CFSB N/A
  • Revenue
  • GANX N/A
  • CFSB $7,484,000.00
  • Revenue This Year
  • GANX N/A
  • CFSB N/A
  • Revenue Next Year
  • GANX N/A
  • CFSB N/A
  • P/E Ratio
  • GANX N/A
  • CFSB N/A
  • Revenue Growth
  • GANX N/A
  • CFSB N/A
  • 52 Week Low
  • GANX $0.95
  • CFSB $6.34
  • 52 Week High
  • GANX $3.19
  • CFSB $13.98
  • Technical
  • Relative Strength Index (RSI)
  • GANX 61.71
  • CFSB 70.48
  • Support Level
  • GANX $1.65
  • CFSB $13.86
  • Resistance Level
  • GANX $2.07
  • CFSB $13.95
  • Average True Range (ATR)
  • GANX 0.16
  • CFSB 0.01
  • MACD
  • GANX 0.05
  • CFSB -0.02
  • Stochastic Oscillator
  • GANX 70.15
  • CFSB 100.00

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About CFSB CFSB Bancorp Inc.

CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.

Share on Social Networks: